Open Access

How can we use new digital approaches to keep the patient at the centre of decision making?

Congress Presentation

About the speakers

Professor Martin Cowie

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
90 presentations
5 followers

Mr Nick Hartshorne-Evans

Preston (United Kingdom of Great Britain & Northern Ireland)
3 presentations
0 follower

Professor Lis Neubeck

Edinburgh Napier University, Edinburgh (United Kingdom of Great Britain & Northern Ireland)
29 presentations
4 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations
18 followers

Doctor Alexander Lyon

Royal Brompton Hospital, London (United Kingdom of Great Britain & Northern Ireland)
32 presentations
11 followers

Professor Friedrich Koehler

Charite University Hospital, Berlin (Germany)
25 presentations
0 follower

Professor Maurizio Volterrani

San Raffaele Pisana Hospital IRCCS, Rome (Italy)
17 presentations
6 followers

5 more presentations in this session

Introduction: Digital health and CVD prevention - natural partners.

Speaker: Professor A. Coats (Coventry, GB)

Thumbnail

Impact on prevention: role of telerehabilitation.

Speaker: Professor M. Volterrani (Rome, IT)

Thumbnail

Impact on diagnosis: role of AI In cardio-oncology.

Speaker: Doctor A. Lyon (London, GB)

Thumbnail

Impact on treatment adherence and disease stability.

Speaker: Professor F. Koehler (Berlin, DE)

Thumbnail

Conclusion: Open questions and perspectives.

Speaker: Professor M. Cowie (London, GB)

Thumbnail

Access the full session

The benefits of digital health interventions in cardiovascular disease

Speakers: Professor M. Cowie, Mr N. Hartshorne-Evans, Professor L. Neubeck, Professor A. Coats, Doctor A. Lyon...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

Open Access

Cancer and heart interactions: from prevention to long-term management

27 August 2021

ESC Premium Access

Severe biventricular myocardial involvement in Systemic sclerosis.

27 August 2021

ESC Premium Access

Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program

27 August 2021

ESC 365 is supported by

logo Novo Nordisk